GlassScriptPhysician profile
Jeffrey S Brindle
NPI 1619906120
$1,410.98
in general payments reported to CMS, 2019-2025
33 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,132 · 2020: $180 · 2021: $49.34 · 2022: $50.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $107.02 | 2019-2021 | |
| Janssen Biotech, INC. | $105.78 | 2019-2020 | |
| Celgene Corporation | $100.64 | 2019-2020 | |
| Amgen INC. | $93.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $84.14 | 2019-2020 | |
| Daiichi Sankyo INC. | $80.16 | 2019-2020 | |
| Tesaro, INC. | $66.92 | 2019 | |
| Exelixis INC. | $63.54 | 2019 | |
| Octapharma USA, INC. | $58.78 | 2019-2020 | |
| Progenics Pharmaceuticals, INC. | $50.55 | 2022 | |
| Clovis Oncology, INC. | $50.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $44.68 | 2019 | |
| Emd Serono, INC. | $39.99 | 2019 | |
| Dova Pharmaceuticals | $39.16 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $39.09 | 2019 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $31.12 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.99 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $27.76 | 2019 | |
| Varian Medical Systems, INC. | $27.09 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.74 | 2019 | |
| Rigel Pharmaceuticals, INC. | $24.07 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.47 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $23.45 | 2019 | |
| Incyte Corporation | $23.36 | 2019 | |
| Pfizer INC. | $23.27 | 2019 | |
| Abbvie INC. | $22.05 | 2019 | |
| Astellas Pharma US INC | $20.38 | 2020 | |
| Sanofi-Aventis U.S. LLC | $17.34 | 2019 | |
| Genzyme Corporation | $15.23 | 2020 | |
| Dendreon Pharmaceuticals LLC | $14.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $12.55 | 2019 | |
| Alexion Pharmaceuticals, INC. | $11.94 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Brindle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.